ARCHIVES

ACS Ask Stronger Federal Action Against Cigarettes

This article is from The Cancer Letter archive.

Vol. 05 No. 47 | November 23, 1979

Download PDF Visit The Full Archive

Related Articles

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

April 20, 2012

Selumetinib Displays Positive Results, 60% with Stable Disease

April 29, 2011

NCCN Launches Outcomes Improvement Program

August 12, 2011

Early ADT Doesn’t Offer Survival Advantage—ASCO

April 27, 2007

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990